EASY TO PRESCRIBE‡
Stores up to 90 days of glucose data, so you and your patients can see patterns and historic trends
FreeStyle Libre 14 day systems users significantly reduced number of hypoglycemia events compared with those using BGM, without increasing A1c1,4
Improved patient-reported treatment satisfaction1,4
FreeStyle LibreLink app** offers easy-to-read5 reports for patients to see their glucose patterns and trends††
FreeStyle LibreLink app** is free to download at the Apple App and Google Play Store
Integration with Libreview§§ makes patient data easily accessible to physicians
No prior authorization will be needed at participating pharmacies§‖‖. For questions about FreeStyle Libre 14 day costs, please have patients call 844-330-5535.‡§.
A rep can keep you informed about new and existing Abbott products.
FreeStyle Libre Pro system offers many features that will make you rethink professional CGM.
*Calibration or coding not required by the user
†Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
‡No paperwork hassles or prior authorization needed at participating pharmacies. This applies to commercially insured patients. This does not apply to beneficiaries of Medicare, Medicaid, or other federal or state healthcare programs. Participating pharmacies are subject to change without notice.
§As a courtesy to its customers, Abbott provides the most up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage of payment for our products or reimburse customers for claims that are denied by third party payors.
‖Based on prescription claims for commercially insured patients using the FreeStyle Libre 14 day System. Does not include Medicare, Medicaid, and uninsured patients. The actual amount a patient pays may vary. The FreeStyle Libre 14 day system requires a prescription.
¶Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
#Glucose readings are not available during 1-hour warmup, when sensor is too hot or too cold or when you see an error or "LO" or "HI" message or no current glucose reading.
**The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle LibreLink app requires registration with LibreView.
††Medicare coverage is available for FreeStyle Libre 14 day systems for cell phone use if FreeStyle LibreLink is used in conjunction with the FreeStyle Libre 14 day readers. Patients must meet Medicare eligibility coverage criteria LCD L33822 (July 2020). Local Coverage Article: Glucose Monitor Policy Article (A52464), May 2017.
‡‡The FreeStyle LibreLink app and the FreeStyle Libre 14 day reader have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
§§The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
‖‖This applies to commercially-insured patients. This does not apply to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. Participating pharmacies are subject to change without notice.
References: 1. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (February 2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 2. FreeStyle Libre 14 day User's Manual. 3. Data on file, Abbott Diabetes Care Inc. 4. Bolinder, Jan, et al. "Novel Glucose-sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-masked, Randomised Controlled Trial." The Lancet 10057, no. 388 (September 2016): 2254-2263. https://doi.org/10.1016/S0140-6736(16)31535-5. 5. Unger, Jeff, Pamela Kushner, and John E. Anderson. “Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care.” Postgraduate Medicine 134, no. 4 (March 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393.
ADC-05528 v8.0 9/21